SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

UBS Maintains Buy on AbbVie, Raises Price Target to $96

UBS maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $79 to $96.

Benzinga · -

UBS maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $79 to $96.